Practical retinoid chemoprophylaxis in solid organ transplant recipients

Dermatologic Therapy

Volumn 18, Issue 1, 2005, Pages 28-33

  Neuhaus, Isaac M ^a   Tope, Whitney D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemoprophylaxis; Organ transplantation; Retinoid

Indexed keywords

ETRETIN; ISOTRETINOIN; PLACEBO; RETINOID;

ACTINIC KERATOSIS; BRAIN PSEUDOTUMOR; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DESQUAMATION; DRUG MONITORING; DRUG TOLERABILITY; EROSION; HUMAN; HYPERCHOLESTEROLEMIA; HYPEROSTOSIS; HYPERTRIGLYCERIDEMIA; ORGAN TRANSPLANTATION; RECIPIENT; REVIEW; RISK FACTOR; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TERATOGENICITY; XEROSIS;

ANTICARCINOGENIC AGENTS; CARCINOMA, SQUAMOUS CELL; CHEMOPREVENTION; HUMANS; KERATOSIS; ORGAN TRANSPLANTATION; RETINOIDS; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 18844422431     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2005.05006.x     Document Type: Review

References (31)

1. Transplant Patient Data Source. Richmond, VA United Network for Organ Sharing [www document]. URL http://www.optn.org/latestData/rptData.asp [accessed August 31, 2004].
2. Berg D, Otley CC. Skin cancer in organ transplant recipients. Epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002: 47: 1-17.
3. Euvrard S, Kanitakis J, Claudy A. Medical progress: skin cancers after organ transplantation. N Engl J Med 2003: 348: 1681-1691.
4. Servilla KS, Burnham DK, Daynes RA. Ability of cyclosporine to promote the growth of transplanted ultraviolet radiation-induced tumors in mice. Transplantation 1987: 44: 291-295.
5. Kelly GE, Meikle W, Sheil AG. Effects of immunosuppressive therapy on the induction of skin tumors by ultraviolet irradiation in hairless mice. Transplantation 1987: 44: 429-434.
6. Hojo M, Morimoto T, Maluccio M et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999: 397: 530-534.
7. Ulrich C, Schmook T, Sachse MM, Sterry W, Stockfleth E. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 2004: 30: 622-627.
8. Veness MJ, Quinn DI, Ong CS et al. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer 1999: 85: 1758-1764.
9. Ong CS, Keogh AM, Kossard S, Macdonald PS, Spratt PM. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999: 40: 27-34.
10. Martinez JC, Otley CC, Stasko T et al. Transplant-Skin Cancer Collaborative. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol 2003: 139: 301-306.
11. Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 1998: 114: 1633-1637.
12. DiGiovanna JJ. Retinoid chemoprevention in the high-risk patient. J Am Acad Dermatol 1998: 39: S82-S85.
13. De Graaf YG, Euvrard S, Bouwes Bavinck JN. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. Dermatol Surg 2004: 30: 656-661.
14. Bellman BA, Eaglstein WH, Miller J. Low dose isotretinoin in the prophylaxis of skin cancer in renal transplant patients. Transplantation 1996: 61: 173.
15. Bouwes Bavinck JN, Tieben LM, Van der Woude FJ et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 1995: 13: 1933-1938.
16. George R, Weightman W, Russ GR, Bannister KM, Mathew TH. Acitretin for chemoprevention of nonmelanoma skin cancers in renal transplant recipients. Australas J Dermatol 2002: 43: 269-273.
17. McKenna DB, Murphy GM. Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin. Br J Dermatol 1999: 140: 656-660.
18. de Sevaux RG, Smit JV, de Jong EM, van de Kerkhof PC, Hoitsma AJ. Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin. J Am Acad Dermatol 2003: 49: 407-412.
19. Smit JV, de Sevaux RG, Blokx WA, van de Kerkhof PC, Hoitsma AJ, de Jong EM. Acitretin treatment in (pre) malignant skin disorders of renal transplant recipients: histologic and immunohistochemical effects. J Am Acad Dermatol 2004: 50: 189-196.
20. Zouboulis CC. Retinoids - which dermatological indications will benefit in the near future? Skin Pharmacol Appl Skin Physiol 2001: 14: 303-315.
21. Odom R. Managing actinic keratoses with retinoids. J Am Acad Dermatol 1998: 39: S74-S78.
22. Euvrard S, Verschoore M, Touraine JL et al. Topical retinoids for warts and keratoses in transplant recipients. Lancet 1992: 340: 48-49.
23. Smit JV, Cox S, Blokx WA, van de Kerhof PC, de Jongh GJ, de Jong EM. Actinic keratoses in renal transplant recipients do not improve with calcipotriol cream and all-trans retinoic acid cream as monotherapies or in combination during a 6-week treatment period. Br J Dermatol 2002: 147: 816-818.
24. Chroni E, Monastirli A, Pasmatzi E et al. Sensorimotor polyneuropathy after a 3-month oral acitretin therapy. Clin Neuropharmacol 2002: 25: 310-312.
25. Geiger JM, Walker M. Is there a reproductive safety risk in male patients treated with acitretin? Dermatology 2002: 205: 105-107.
26. Martinez JC, Otley CC, Euvrard S, Arpey CJ, Stasko T. International Transplant-Skin Cancer Collaborative. Complications of systemic retinoid therapy in organ transplant recipients with squamous cell carcinoma. Dermatol Surg 2004: 30: 662-666.
27. McKerrow KJ, MacKie RM, Lesko MJ, Pearson C. The effect of oral retinoid therapy on the normal human immune system. Br J Dermatol 1988: 119: 313-320.
28. Shuttleworth D, Marks R, Griffin PJ, Salaman JR. Treatment of cutaneous neoplasia with etretinate in renal transplant recipients. Q J Med 1988: 68: 717-725.
29. Tan SR, Tope WD. Effect of acitretin on wound healing in organ transplant recipients. Dermatol Surg 2004: 30: 667-673.
30. Stasko T, Brown MD, Carucci JA et al. International Transplant-Skin Cancer Collaborative; European Skin Care in Organ Transplant Patients Network. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004: 30: 642-650.
31. Otley CC, Coldiron BM, Stasko T, Goldman GD. Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. Arch Dermatol 2001: 137: 459-463.